These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma. Sommer C; Boldajipour B; Kuo TC; Bentley T; Sutton J; Chen A; Geng T; Dong H; Galetto R; Valton J; Pertel T; Juillerat A; Gariboldi A; Pascua E; Brown C; Chin SM; Sai T; Ni Y; Duchateau P; Smith J; Rajpal A; Van Blarcom T; Chaparro-Riggers J; Sasu BJ Mol Ther; 2019 Jun; 27(6):1126-1138. PubMed ID: 31005597 [TBL] [Abstract][Full Text] [Related]
3. Engineering Tolerance toward Allogeneic CAR-T Cells by Regulation of MHC Surface Expression with Human Herpes Virus-8 Proteins. Wang X; Cabrera FG; Sharp KL; Spencer DM; Foster AE; Bayle JH Mol Ther; 2021 Feb; 29(2):718-733. PubMed ID: 33554868 [TBL] [Abstract][Full Text] [Related]
4. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256 [TBL] [Abstract][Full Text] [Related]
5. Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells. Bai Z; Lundh S; Kim D; Woodhouse S; Barrett DM; Myers RM; Grupp SA; Maus MV; June CH; Camara PG; Melenhorst JJ; Fan R J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34006631 [TBL] [Abstract][Full Text] [Related]
6. Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery. Sommer C; Cheng HY; Nguyen D; Dettling D; Yeung YA; Sutton J; Hamze M; Valton J; Smith J; Djuretic I; Chaparro-Riggers J; Sasu BJ Mol Ther; 2020 Oct; 28(10):2237-2251. PubMed ID: 32592688 [TBL] [Abstract][Full Text] [Related]
7. Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering. Han X; Cinay GE; Zhao Y; Guo Y; Zhang X; Wang P Mol Ther; 2017 Nov; 25(11):2466-2476. PubMed ID: 28784559 [TBL] [Abstract][Full Text] [Related]
8. Fully human antibody V Wang G; Zhou X; Fucà G; Dukhovlinova E; Shou P; Li H; Johnston C; Mcguinness B; Dotti G; Du H J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795386 [TBL] [Abstract][Full Text] [Related]
9. CAR T-Cell Therapy in Hematological Malignancies. Haslauer T; Greil R; Zaborsky N; Geisberger R Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445701 [TBL] [Abstract][Full Text] [Related]
10. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma. Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J Front Immunol; 2023; 14():1219872. PubMed ID: 37736096 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation. Khan AN; Chowdhury A; Karulkar A; Jaiswal AK; Banik A; Asija S; Purwar R Front Immunol; 2022; 13():886546. PubMed ID: 35677038 [TBL] [Abstract][Full Text] [Related]
12. Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells. Friedman KM; Garrett TE; Evans JW; Horton HM; Latimer HJ; Seidel SL; Horvath CJ; Morgan RA Hum Gene Ther; 2018 May; 29(5):585-601. PubMed ID: 29641319 [TBL] [Abstract][Full Text] [Related]
13. A tandem CD19/CD20 CAR lentiviral vector drives on-target and off-target antigen modulation in leukemia cell lines. Schneider D; Xiong Y; Wu D; Nӧlle V; Schmitz S; Haso W; Kaiser A; Dropulic B; Orentas RJ J Immunother Cancer; 2017; 5():42. PubMed ID: 28515942 [TBL] [Abstract][Full Text] [Related]
14. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review. Tang C; Zhang Y Pathol Res Pract; 2024 Oct; 262():155518. PubMed ID: 39146830 [TBL] [Abstract][Full Text] [Related]
15. Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123. Morgan MA; Kloos A; Lenz D; Kattre N; Nowak J; Bentele M; Keisker M; Dahlke J; Zimmermann K; Sauer M; Heuser M; Schambach A Viruses; 2021 Jul; 13(7):. PubMed ID: 34372571 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Marcus A; Eshhar Z Expert Opin Biol Ther; 2014 Jul; 14(7):947-54. PubMed ID: 24661086 [TBL] [Abstract][Full Text] [Related]
17. Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line. Kang CH; Kim Y; Lee HK; Lee SM; Jeong HG; Choi SU; Park CH Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33271901 [TBL] [Abstract][Full Text] [Related]
18. Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy. Dai Z; Hu X; Jia X; Liu J; Yang Y; Niu P; Hu G; Tan T; Zhou J J Cell Physiol; 2021 Aug; 236(8):5832-5847. PubMed ID: 33432627 [TBL] [Abstract][Full Text] [Related]
19. Placental circulating T cells: a novel, allogeneic CAR-T cell platform with preserved T-cell stemness, more favorable cytokine profile, and durable efficacy compared to adult PBMC-derived CAR-T. Ruggeri Barbaro N; Drashansky T; Tess K; Djedaini M; Hariri R; He S; van der Touw W; Karasiewicz K J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38684370 [TBL] [Abstract][Full Text] [Related]
20. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes. Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]